Arcus collaborates with Genentech for two randomised clinical studies of AB928

This article was originally published here

The collaboration will utilize the MORPHEUS Phase 1b/2 platform for rapid and efficient combination development, with upfront randomization versus control groups, in two studies: Third-line metastatic CRC: two

The post Arcus collaborates with Genentech for two randomised clinical studies of AB928 appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply